Bayer (0P6S) Receives a Hold from UBS
UBS analyst Geoff Haire maintained a Hold rating on Bayer today and set a price target of €32.00.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Haire is an analyst with an average return of -2.5% and a 47.18% success rate. Haire covers the Basic Materials sector, focusing on stocks such as Wacker Chemie AG, Evonik, and K+S Aktiengesellschaft.
In addition to UBS, Bayer also received a Hold from TipRanks – OpenAI’s OpenAI General GB in a report issued on February 3. However, on February 6, Goldman Sachs maintained a Buy rating on Bayer (LSE: 0P6S).
The company has a one-year high of €46.89 and a one-year low of €18.38. Currently, Bayer has an average volume of 3.58M.
Read More on GB:0P6S:
Disclaimer & DisclosureReport an Issue
- Bristol Myers price target raised to $68 from $64 at BofA
- Truist incrementally positive on Bristol Myers after Bayer asundexian data
- Bayer says Asundexian showed 26% reduction in stroke in Phase III study
- Bayer investing over C$45M to build canola research, development facility
- Bayer, Vanderbilt University Medical Center enter five-year collaboration
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.